arrow
P

Paul A. Carpenter

Fred Hutch Cancer Center
H指数:64
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Late Effects and Quality of Life by Donor Type in Long-Term Survivors of Severe Aplastic Anemia after Hematopoietic Cell Transplantation

比较造血干细胞移植后重型再生障碍性贫血长期存活者中供者类型对晚期效应和生活质量的影响

2026-08-210
PRE
ASTCT Clinical Practice Recommendations for Transplantation in Classical Hodgkin Lymphoma

ASTCT关于经典霍奇金淋巴瘤移植治疗的临床实践建议

2025-12-300
OAAI
Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid Malignancies

造血干细胞移植后低剂量阿扎胞苷维持治疗在具有高风险髓系恶性肿瘤的儿科人群中的应用

2025-12-050
PRE
Corrigendum to ‘American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients’ [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016]

勘误:‘American Society for Transplantation and Cellular Therapy Series #10: Management of Parainfluenza and Human Metapneumovirus Infections in Hematopoietic Cell Transplantation and Cellular Therapy Recipients’ [Transplantation and Cellular Therapy 31 (2025) 624-638/ https://doi.org/10.1016/j.jtct.2025.06.016]

2025-11-190
PRE
Outcomes following hematopoietic cell transplantation for children, adolescents and young adults with relapsed acute lymphoblastic leukemia

儿童、青少年和年轻成人复发急性淋巴细胞白血病造血细胞移植后的结局

2025-11-160
PRE
Respiratory Virus Infections and Pulmonary Impairment After Allogeneic Hematopoietic Cell Transplantation

同种异基因造血细胞移植后的呼吸道病毒感染与肺功能损害

2025-10-010
PRE
Risk Biomarkers of Chronic Graft-versus-host disease in Children aged 10 years or younger and Children/adults Older than 10 years

慢性移植物抗宿主病在10岁及以下儿童和10岁以上儿童/成人中的风险生物标志物

2025-09-200
OAAI
American Society for Transplantation and Cellular Therapy Series #11: Updated Cytomegalovirus Guidelines in Hematopoietic Cell Transplant and Cellular Therapy Recipients

美国移植与细胞治疗学会系列 #11:造血细胞移植和细胞治疗受者巨细胞病毒指南更新

2025-06-010
OAAI
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy

ASTCT、CIBMTR、EBMT和APBMT关于造血细胞移植相关血栓性微血管病(TA-TMA)导向治疗反应标准的共识声明

2025-06-010
OAAI